{
    "2019-03-01": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Novo Nordisk files for a label update for Fiasp® to the EMA and the FDA seeking approval for use in children and adolescents",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Fiasp®",
                        "EMA",
                        "FDA",
                        "label update",
                        "children",
                        "adolescents"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}